Skip to content
Screener

Alumis Inc. ALMS Contract Liabilities, Non-Current

Contract Liabilities, Non-Current at other companies

Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$14.31M-21.5%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.52B+693%
Enterprise value$3.49B+955%
P/S418.8×—

Profitability

See full
Operating margin-5,364%—
Net margin-2,825.7%—
FCF margin-4,487.4%—

Returns & leverage

See full
Return on equity-64.6%—
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010
(in thousands, except share and per share amounts)March 31, 2026December 31, 2025
Operating lease liabilities, non-current31,22232,244
Deferred tax liability2,1402,140
Share repurchase liability94123
Deferred revenue, non-current—2,611
Other liabilities, non-current207207
Total liabilities104,567110,643
Commitments and contingencies (Note 9)
Stockholders’ equity:

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s contract liabilities, non-current?
Alumis Inc. (ALMS) reported contract liabilities, non-current of $2.61M in Q4 2025.

Ask your AI about Alumis Inc.'s contract liabilities, non-current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude